Ventas (NYSE:VTR – Get Free Report) posted its quarterly earnings data on Tuesday. The real estate investment trust reported $0.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.98 by $0.01, Zacks reports. The business had revenue of $1.83 billion during the quarter, compared to analysts’ expectations of $1.77 billion. The business’s quarterly revenue was up 23.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.88 EPS.
Ventas Stock Performance
VTR opened at $83.22 on Wednesday. The firm’s fifty day moving average is $87.67 and its 200 day moving average is $86.31. Ventas has a fifty-two week low of $68.15 and a fifty-two week high of $101.60.
Ventas Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Wednesday, September 30th were paid a dividend of $0.52 per share. The ex-dividend date was Wednesday, September 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%.
Analyst Upgrades and Downgrades
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust focused on healthcare and senior housing properties. The company owns, manages and develops a diversified portfolio of healthcare-related real estate, including senior living communities, medical office buildings, life science and innovation centers, and other properties serving healthcare providers and institutions.
Ventas generally leases its properties to healthcare operators, physicians, health systems, universities and research organizations.
Further Reading
- Five stocks we like better than Ventas
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
